OTC - ACTIVE INGREDIENT SECTION
Active Ingredients
Lidocaine HCl 4%
Menthol 1%
Active Ingredients
Lidocaine HCl 4%
Menthol 1%
Cool Pain Relief
Uses
For the temporary relief of pain.
Warnings
FOR EXTERNAL USE ONLY. NOT INTENDED FOR INGESTION DONT USE ONLARGE AREAS OF THE BODY OR ON CUT, IRRITATED OR SWOLLEN SKIN. Use only as directed, avoid contact with eyes and mucus membranes If pregnant or breast-feeding, ask a health care professional before use.
CHILD RESISTANT PACKAGING. CLOSE CAP TIGHTLY AFTER EACH USE. If swallowed, get medical help
Keep package as it contains important information.
THC FREE • NOT TESTED ON ANIMALS
Keep out of reach of children.
If swallowed, get medical help, or contact a Poison Control Central right away.
Directions
Purified water, Arnica, Glycerine, Frankincense, Hemp seed oil, Glyceryl stearate, Cetearyl Alcohol, Comfrey Essential Oil, Vitamin E, Eucalyptus Essential Oil, Turmeric Essential Oil, Black Pepper Essential Oil, Chamomile, Helichrysum, Bergamot
Sore muscles, aching joints, gout flare-ups and body pain can make your life miserable.
Experience the cooling and instant pain-relleving benefits from a physician formulated "no mess" gel like roll-on. It glides on your skin and is
quickly absorbed. The lcy-cold feeling helps alleviate pain associated with bruising, swelling, stiffness, inflammation, pain and muscle soreness
and more. An advantage of hemp seed oil as a topical brings nutrition which helps care for the skin. Emu oil nourishes and hydrates skin
damaged by radiation therapy
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58292-001 | 58292-001-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 06d13207-c219-8cee-e063-6394a90a21a0 | e4b9aeef-7c12-43f0-b868-a5193a7f7bd5 | 2023-10-03 | Warnings | e4b9aeef-7c12-43f0-b868-a5193a7f7bd5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.